ARQTArcutis Biotherapeutics

Median target
$36
calls from the last 12 months
Implied return
+36.1%
median target vs. price
Coverage
7 analysts · 9 calls
updated in the last 12 months
Consensus
7/0/0+7 net
Buy / Hold / Sell

Which analysts are behind ARQT's consensus?

See every current rating, price target and the analysts' track records for Arcutis Biotherapeutics — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 7 analysts with calls on ARQT updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

ARQT elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)

DateSourceWhoActionDetailAmount
2026-09-16InsidersMatsuda MasaruSee RemarksInsider sale3.7K sh @ $25.00 · planned trade$92K
2026-09-15InsidersWelgus Howard G.DirectorInsider sale4.7K sh @ $24.18 · planned trade$114K
2026-09-08InsidersMatsuda MasaruSee RemarksInsider sale10.0K sh @ $25.03 · planned trade$250K
2026-08-27InsidersCurran TerrieDirectorInsider sale27.1K sh @ $25.03$677K
2026-08-27InsidersCurran TerrieDirectorInsider sale11.1K sh @ $25.03$279K
2026-08-20InsidersCurran TerrieDirectorInsider sale1.1K sh @ $26.04$28K
2026-08-19InsidersBurnett PatrickSee RemarksInsider sale1.7K sh @ $27.00$46K
2026-08-17InsidersWelgus Howard G.DirectorInsider sale4.7K sh @ $26.18 · planned trade$124K
2026-08-12InsidersBurnett PatrickSee RemarksInsider sale6.7K sh @ $26.08$175K
2026-08-11InsidersBurnett PatrickSee RemarksInsider sale8.3K sh @ $26.52$220K

More: congressional trades on ARQT · insider activity · executive branch · trending